MME and breast neoplasm: CDK11A, MME and SEPT6 were also found to altered in 6.2%, 4.5%, and 3.7%, respectively, in a panel of 1062 breast tumours from the Cancer Genome Atlas project [83, 84], either through mutation, amplification, deletion or altered gene expression.